Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $43.1100 (-1.64%) ($43.1100 - $43.1100) on Thu. Apr. 29, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.58% (three month average) | RSI | 45 | Latest Price | $43.1100(-1.64%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX advances 0.8% a day on average for past five trading days. | Weekly Trend | TGTX declines -1.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(67%) ARKG(63%) ARKK(59%) IBB(58%) IWO(58%) | Factors Impacting TGTX price | TGTX will decline at least -1.79% in a week (0% probabilities). VIXM(-42%) VXX(-36%) UUP(-18%) UNG(-3%) TLT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.79% (StdDev 3.58%) | Hourly BBV | -0.2 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $44.24 | 5 Day Moving Average | $43.32(-0.48%) | 10 Day Moving Average | $42.65(1.08%) | 20 Day Moving Average | $44.24(-2.55%) | To recent high | -20.4% | To recent low | 7.7% | Market Cap | $5.46b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |